These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9284902)

  • 1. E64d, a membrane-permeable cysteine protease inhibitor, attenuates the effects of parathyroid hormone on osteoblasts in vitro.
    Murray EJ; Grisanti MS; Bentley GV; Murray SS
    Metabolism; 1997 Sep; 46(9):1090-4. PubMed ID: 9284902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.
    Murray SS; Grisanti MS; Bentley GV; Kahn AJ; Urist MR; Murray EJ
    Exp Cell Res; 1997 Jun; 233(2):297-309. PubMed ID: 9194492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTH-induced osteoblast contraction is mediated by cysteine proteases.
    Tram KK; Murray SS; Lee DB; Murray EJ
    Kidney Int; 1993 Mar; 43(3):693-9. PubMed ID: 8384280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of calcium-activated neutral protease activity and regulation by parathyroid hormone in mouse osteoblastic cells.
    Tram KK; Spencer MJ; Murray SS; Lee DB; Tidball JG; Murray EJ
    Biochem Mol Biol Int; 1993 Apr; 29(5):981-7. PubMed ID: 8508148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTH-mediated osteoblast retraction: possible participation of the calpain pathway.
    Murray EJ; Tram KK; Spencer MJ; Tidball JG; Murray SS; Lee DB
    Miner Electrolyte Metab; 1995; 21(1-3):184-8. PubMed ID: 7565446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-induced retraction of MC3T3-E1 osteoblastic cells is attenuated by the calpain inhibitor N-Ac-Leu-Leu-norleucinal.
    Murray EJ; Tram KK; Murray SS; Lee DB
    Metabolism; 1995 Feb; 44(2):141-4. PubMed ID: 7869906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment.
    Schiller PC; D'Ippolito G; Roos BA; Howard GA
    J Bone Miner Res; 1999 Sep; 14(9):1504-12. PubMed ID: 10469278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
    Koh AJ; Beecher CA; Rosol TJ; McCauley LK
    Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I.
    Kostenuik PJ; Harris J; Halloran BP; Turner RT; Morey-Holton ER; Bikle DD
    J Bone Miner Res; 1999 Jan; 14(1):21-31. PubMed ID: 9893062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
    van der Horst G; Farih-Sips H; Löwik CW; Karperien M
    J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bovine parathyroid hormone withdrawal on MC3T3-E1 cell proliferation and phosphorus metabolism.
    Liu S; Zhu W; Li S; Cui T; Li Z; Zhang B; Li Z; Wu J; Liang X; Lin Z; Shi W
    PLoS One; 2015; 10(3):e0120402. PubMed ID: 25775025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
    Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
    J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells.
    Swarthout JT; D'Alonzo RC; Selvamurugan N; Partridge NC
    Gene; 2002 Jan; 282(1-2):1-17. PubMed ID: 11814673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of zinc in regulation of protein tyrosine phosphatase activity in osteoblastic MC3T3-E1 cells: zinc modulation of insulin-like growth factor-I's effect.
    Yamaguchi M; Fukagawa M
    Calcif Tissue Int; 2005 Jan; 76(1):32-8. PubMed ID: 15477998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
    Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
    J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein-7 modifies the effects of insulin-like growth factors and intermittent parathyroid hormone (1-34) on human periodontal ligament cell physiology in vitro.
    Lossdörfer S; Abuduwali N; Jäger A
    J Periodontol; 2011 Jun; 82(6):900-8. PubMed ID: 21189084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C, and inhibitor of bone resorption produced by osteoblasts.
    Lerner UH; Johansson L; Ranjsö M; Rosenquist JB; Reinholt FP; Grubb A
    Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cells: role of insulin-like growth factor (IGF)-I and IGF-binding protein-5.
    Nasu M; Sugimoto T; Kaji H; Chihara K
    J Endocrinol; 2000 Nov; 167(2):305-13. PubMed ID: 11054645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.
    Murray EJ; Bentley GV; Grisanti MS; Murray SS
    Exp Cell Res; 1998 Aug; 242(2):460-9. PubMed ID: 9683533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.